Ping An Biomedical Co., Ltd. (PASW)
NASDAQ: PASW · Real-Time Price · USD
0.506
+0.012 (2.35%)
At close: Dec 5, 2025, 4:00 PM EST
0.490
-0.016 (-3.18%)
After-hours: Dec 5, 2025, 7:57 PM EST
Ping An Biomedical Income Statement
Financials in millions CNY. Fiscal year is October - September.
Millions CNY. Fiscal year is Oct - Sep.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '25 Mar 31, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 |
| Revenue | 60.13 | 87.62 | 82.56 | 114.55 | 99.52 | 55.46 |
| Revenue Growth (YoY) | -37.53% | 6.13% | -27.92% | 15.10% | 79.43% | - |
| Cost of Revenue | 59.09 | 82.21 | 78.32 | 100.4 | 85.25 | 44.8 |
| Gross Profit | 1.04 | 5.42 | 4.24 | 14.14 | 14.27 | 10.67 |
| Selling, General & Admin | 5.51 | 5.3 | 3.6 | 3.52 | 3.76 | 3.05 |
| Operating Expenses | 5.76 | 5.42 | 3.63 | 3.33 | 6 | 6.21 |
| Operating Income | -4.72 | -0 | 0.61 | 10.82 | 8.27 | 4.46 |
| Interest Expense | -0.35 | -0.71 | -1.74 | -1.57 | -1.36 | -1.04 |
| Interest & Investment Income | 0 | 0 | 0.16 | 0.04 | 0 | 0.01 |
| Currency Exchange Gain (Loss) | -0.01 | -0.01 | 0.21 | -0 | 0.19 | 0.05 |
| Other Non Operating Income (Expenses) | -0.09 | 0.03 | 0.8 | 0.34 | 0.72 | 0 |
| Pretax Income | -5.16 | -0.68 | 0.04 | 9.63 | 7.82 | 3.48 |
| Income Tax Expense | 0.6 | 0.6 | 1.04 | 2.4 | 2.61 | 1.55 |
| Net Income | -5.75 | -1.28 | -0.99 | 7.23 | 5.21 | 1.92 |
| Net Income to Common | -5.75 | -1.28 | -0.99 | 7.23 | 5.21 | 1.92 |
| Net Income Growth | - | - | - | 38.61% | 170.96% | - |
| Shares Outstanding (Basic) | 18 | 18 | 18 | 18 | 18 | 18 |
| Shares Outstanding (Diluted) | 18 | 18 | 18 | 18 | 18 | 18 |
| EPS (Basic) | -0.32 | -0.07 | -0.06 | 0.40 | 0.29 | 0.11 |
| EPS (Diluted) | -0.32 | -0.07 | -0.06 | 0.40 | 0.29 | 0.11 |
| EPS Growth | - | - | - | 38.61% | 170.96% | - |
| Free Cash Flow | 11.04 | 14.63 | -6.08 | 21.06 | -31.4 | -7.18 |
| Free Cash Flow Per Share | 0.61 | 0.81 | -0.34 | 1.17 | -1.74 | -0.40 |
| Gross Margin | 1.73% | 6.18% | 5.14% | 12.35% | 14.34% | 19.23% |
| Operating Margin | -7.85% | -0.00% | 0.74% | 9.44% | 8.31% | 8.04% |
| Profit Margin | -9.57% | -1.47% | -1.20% | 6.31% | 5.24% | 3.47% |
| Free Cash Flow Margin | 18.35% | 16.70% | -7.37% | 18.39% | -31.55% | -12.95% |
| EBITDA | -4.71 | 0.01 | 0.65 | 10.84 | 8.29 | 4.46 |
| EBITDA Margin | -7.84% | 0.01% | 0.78% | 9.46% | 8.33% | 8.05% |
| D&A For EBITDA | 0.01 | 0.01 | 0.03 | 0.02 | 0.02 | 0 |
| EBIT | -4.72 | -0 | 0.61 | 10.82 | 8.27 | 4.46 |
| EBIT Margin | -7.85% | -0.00% | 0.74% | 9.44% | 8.31% | 8.04% |
| Effective Tax Rate | - | - | 2484.34% | 24.92% | 33.32% | 44.67% |
Source: S&P Capital IQ. Standard template.
Financial Sources.